Alexandre Behouche

Alexandre Behouche

Auto-generated profile, based on publicly available information

Alexandre Behouche

Anaesthesia and Intensive Care Unit, Grenoble University Hospital, Grenoble, France

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
PDF file
PMPierre-Henri Moury
Pierre-Henri Moury
RZRomain Zunarelli
Romain Zunarelli
Sébastien BaillySébastien Bailly
Sébastien Bailly
ZDZoé Durand
Zoé Durand
ABAlexandre Béhouche
Alexandre Béhouche
PAPierre Albaladejo
Pierre Albaladejo

16 March 2023 in Anaesthesia Critical Care & Pain Medicine
Verified
Journal Article
Closed access
JPJean-François Payen
Jean-François Payen
CSClotilde Schilte
Clotilde Schilte
BBBarthelemy Bertrand
Barthelemy Bertrand
ABAlexandre Behouche
Alexandre Behouche

20 December 2024 in Anaesthesia Critical Care & Pain Medicine
Verified
Journal Article
Open access
VLVincent Legros
Vincent Legros
YHYannick Hourmant
Yannick Hourmant
LGLouis Genty
Louis Genty
KAKarim Asehnoune
Karim Asehnoune
QRQuentin de Roux
Quentin de Roux
AJArthur James
Arthur James
Indications for Veno-venous (VV) or veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) after trauma rely on poor evidence. The main aims were to describe the population of trauma patients requiring either VV or VA ECMO and report their clinical management and outcomes. An observational multicentre retrospective study was conducted in 17 Level 1 trauma centres in France between January 2010 and December 2021. All patients admitted for major trauma were screened for inclusion, and those receiving either VV ECMO or VA ECMO were included. The primary outcome was in-hospital mortality. Among the 52,851 patients screened, 179 were included, with 143 supported by VV ECMO (median [Q1-Q3] age 32 years [24-48]; men 83.5%; injury severity score [ISS] 33 [25-43] and 76 (53.6%) with a traumatic brain injury [TBI]) and 36 supported by VA ECMO (median age 39 years [25-55]; men 88.9%; ISS 36 [25-56] and 23 (63.9%) with a TBI). In the VV ECMO group, three indications for ECMO implementation were chest injuries (n = 68, 47.6%), ventilator-associated pneumonia (VAP; n = 57, 39.9%), and extra-respiratory acute respiratory distress syndrome (ARDS; n = 57, 39.9%). In the VV ECMO group, 45.8% (n = 65) died in the hospital, with 33 (48.5%) deaths following cannulation for chest injuries, 22 (39.3%) following cannulation for VAP, and 10 (55.6%) following cannulation for extrapulmonary ARDS. In the VA ECMO group, 75.0% (n = 27) died during their hospital stay. In-hospital mortality of trauma patients requiring ECMO for refractory ARDS varied according to indications. The best prognosis was observed in the subgroup of pneumonia-induced ARDS patients.

19 April 2025 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
CBCoralie Boudin
Coralie Boudin
AFAmandine Faure
Amandine Faure
ABAlexandre Behouche
Alexandre Behouche
OOOlivier Ormezzano
Olivier Ormezzano
HEHélène Eysseric-Guérin
Hélène Eysseric-Guérin
TWThéo Willeman
Théo Willeman

11 April 2023 in Artificial Organs
Verified
Journal Article
Open access
ABAlexandre Behouche
Alexandre Behouche
LGLucie Gaide‐Chevronnay
Lucie Gaide‐Chevronnay
JPJuliette Piot
Juliette Piot
MDMaxime Durost
Maxime Durost
AAAnais Adolle
Anais Adolle
PAPierre Albaladejo
Pierre Albaladejo
Background: Extubation strategy in extracorporeal life support patients remains unclear, and literature only reports studies with significant biases. Objectives: To explore the prognostic impact of an early ventilator‐weaning strategy in assisted patients after controlling for confounding factors. Methods: A 10‐year retrospective study included 241 patients receiving extracorporeal life support for at least 48 h, corresponding to a total of 977 days spent on assistance. The a priori probability of extubation for each day of assistance was calculated according to daily biological examinations, drug doses, clinical observations, and admission data to pair each day containing an extubation with one on which the patient was not extubated. The primary outcome was survival at day 28. The secondary outcomes were survival at day 7, respiratory infections, and safety criteria. Results: Two similar cohorts of 61 patients were generated. Survival at day 28 was better in patients extubated under assistance in univariate and multivariate (HR = 0.37 [0.2–0.68], p ‐value = 0.002) analyses. Patients who underwent failed early extubation did not have a different prognosis from those without early extubation. Successful early extubation was associated with a better outcome than a failed or no attempt at early extubation. Survival at day 7 and the rate of respiratory infections were better in early‐extubated patients. Safety data did not differ between the two groups. Conclusions: Early extubation during assistance was associated with a superior outcome in our propensity‐matched cohort study. The safety data were reassuring. However, due to the lack of prospective randomized studies, the causality remains uncertain.

22 February 2024 in Artificial Organs
Verified
Journal Article
Open access
ABAlexandre Behouche
Alexandre Behouche
ASAlexandre Sebestyen
Alexandre Sebestyen
LGLaura Guillet
Laura Guillet
HDHerve Durand
Herve Durand
PCPhilippe Chaffanjon
Philippe Chaffanjon
DBDamien Bedague
Damien Bedague
A 64-year-old patient required emergency surgery with high risk of intubation failure, without any possibility to perform neither a direct transtracheal access nor VV-ECMO canulation. The patient was managed thanks to a VA-ECMO despite the absence of cardiac function impairment. This report describes perioperative challenges and management of this unconventional case with favorable outcome.